Last Price$29.3(3.2%)
Market Cap$1,656.1M
(413.0%)
Industry median - (169.7%)
5Y Historical average - 3,208.7%
(424.4%)
Industry median - (172.9%)
5Y Historical average - 3,198.8%
(8.2%)
Industry median - (41.2%)
5Y Historical average - (6.2%)
(11.5%)
Industry median - (39.5%)
5Y Historical average - (14.8%)
JANX Capital Allocation Rating
JANX Capital Allocation rating
4.3
JANX Capital Allocation rating performance
JANX Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with JANX Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$1,656.1M | 4.3 | (413.0%) | (424.4%) | (183.7%) | (8.2%) | (11.5%) | 17.0% | 0.0% | |
$124.8B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$77.0B | 6.0 | 25.7% | 18.1% | 25.3% | 13.7% | 10.3% | 1.4% | 4.1% | |
$34.4B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$30.7B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$24.0B | 4.7 | (37.8%) | (45.6%) | (6.7%) | (3.5%) | (6.5%) | 0.8% | 0.0% | |
$14.5B | 5.5 | 14.5% | 9.6% | 37.0% | 12.9% | 6.4% | (2.8%) | 3.6% | |
$13.8B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.3% | |
$13.4B | 6.2 | 11.0% | 3.5% | 15.1% | 7.7% | 5.5% | 1.0% | 0.5% | |
$13.3B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$1,846.9M | 4.3 | (43.2%) | (47.6%) | (43.3%) | (25.3%) | (27.4%) | 1.2% | 0.0% |
FAQ
What is the Janux Therapeutics, Inc. (JANX) ROIC (Return on Invested Capital)?
The Janux Therapeutics, Inc. (JANX) ROIC is (413.0%), compared to the industry median of ((169.7%)) and the 5-year historical average of 3,208.7%.
What is the Janux Therapeutics, Inc. (JANX) ROIC minus WACC (Weighted Average Cost of Capital)?
The Janux Therapeutics, Inc. (JANX) ROIC minus WACC is (424.4%), compared to the industry median of ((172.9%)) and the 5-year historical average of 3,198.8%.
What is the Janux Therapeutics, Inc. (JANX) ROE (Return on Equity)?
The Janux Therapeutics, Inc. (JANX) ROE is (8.2%), compared to the industry median of ((41.2%)) and the 5-year historical average of (6.2%).
What is the Janux Therapeutics, Inc. (JANX) ROCE (Return on Capital Employed)?
The Janux Therapeutics, Inc. (JANX) ROCE is (11.5%), compared to the industry median of ((39.5%)) and the 5-year historical average of (14.8%).